ImmunityBio converts from Immunomedics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics

IBRX 2.045

-3.1%

1:53 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: TripleE3	4/15/2025 1:56:23 PM
	Read Replies (1) of 1229

ImmunityBio(IBRX) also reported preliminary net product revenue of about $16.5 million for Q1, up from $7.2 million in Q4. 100%+ quarter over quarter growth. IBRX down. Investor day tomorrow. Ideally we will see some REALLY good news tomorrow but I am very concerned. If they have REALLY good news why would the do a a secondary before releasing it?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next